Add Formweb to your mobile device
Search results for:
buprenorphine-naloxone
buprenorphine-naloxone
Brand names: Suboxone , Zubsolv
| Form | Strength | ANAN | ASMP | LACH | LALK | LOHH | LOLR | LOWC | SDSD | SESE | SFSF | Formulary Status |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FILM, SUBLINGUAL | 2 mg-0.5 mg, 4 mg-1 mg, 8 mg-2 mg, 12 mg-3 mg | non formulary | ||||||||||
| TABLET, SUBLINGUAL | 2.9 mg-0.71 mg | formulary restricted or psychiatry for microinduction dosing |
Last updated: Jun. 19, 2025
- Black Box Warning: Implant: Implant Migration, Protrusion, Expulsion, and Nerve Damage Associated with Insertin and Removal
- Therapeutic Interchange: T.I.
- Restricted: Zubsolv is formulary restricted or psychiatry for microinduction dosing.
Conversion table : Suboxone to Buprenorphine sublingual tablets
Opioid Partial Agonists
Medication
Ordered
Brand Name
Available Dosages
Frequency
Formulary Medication
Equivalent
Dose
Frequency
Buprenorphine / Naloxone
Suboxone
Sublingual Film
2 mg / 0.5 mg
Daily
Buprenorphine Sublingual Tablets
2 mg
Daily
4 mg / 1 mg
Buprenorphine Sublingual Tablets
4 mg
(Dispense two 2 mg tablets)
8 mg / 2 mg
Buprenorphine Sublingual Tablets
8 mg
12 mg / 3 mg
Buprenorphine Sublingual Tablets
12 mg
(Dispense 8 mg and two
2 mg tablets
Note: Naloxone is present in the formulation of Suboxone to prevent drug abuse and diversion.
In the inpatient setting, Naloxone is not a necessary component of this regimen.
Buprenorphine